Cancer
|
Development of individualized radiotherapy and biological target; Development of novel treatment approaches against metastasis |
|
|
Email: jing.cai@polyu.edu.hk |
Image-guided radiation therapy, MRI-guided radiation therapy, 4D imaging techniques, artifitial intelligence applications in radiation therapy, functional imaging, novel treatment techniques |
|
Email: lt.lin@polyu.edu.hk |
Photoacoustic imaging-guided photothermal therapy; Image-guided nanoparticle treatments; radiosensitizing agents |
|
Email: helen.law@polyu.edu.hk |
Ultrasound, Computed Tomography, Magnetic Resonance Imaging and Nuclear medicine for cancer diagnosis |
|
Email: jungsun.yoo@polyu.edu.hk |
Dr.Yoo's group focuses on development of in vivo imaging techniques using the power of light to revolutionize clinical practice in cancer diagnosis. We are interested in development of novel fluorescence molecular imaging technologies and multimodal imaging strategies for intraoperative guidance, diagnosis, and prognostication of cancer. Current projects include development of spectral reflectance imaging system to visualize peripheral nerves during cancer surgry and single cell resolution pharmacokinetic and pharmacodynamic imaging of nanomedicine to treat cancer |
|
Email: wing.chi.chan@polyu.edu.hk |
AI application in cancer imaging, radiomics |
|
Email: michael.ying@polyu.edu.hk |
Ultrasound diagnosis of head and neck cancers and their associated metastases; Computer-aided diagnosis of cancers |
|
Email: helen.law@polyu.edu.hk |
Molecular and epigenetic markers related to carcinogenesis and autophagy |
|
Immune evasion of colorectal cancer |
|
Management of rectal cancer radiotherapy side effects |
|
|
Email: shara.lee@polyu.edu.hk |
Use of photobiomodulation (BPM)/low-level laser therapy for the management of radiation-induced dermatitis and oral mucositis |
|
Targeting signaling pathways in tumor microenvironment for cancer treatment |
|
| Email: alvin.ma@polyu.edu.hk |
1. Molecular mechanism of leukemogenesis 2. Developing zebrafish model of human leukemia 3. High throughput durg screening for novel target therapuetic agents of luekemia |
| Email: cl.huang@polyu.edu.hk |
1. Role of Long Non-coding RNAs in Myeloproliferative Neoplasms and Myeloid Malignancies 2. Mechanisms in Regulating Drug Resistance of Chronic Myeloid Leukaemia |
|
Email: helen.law@polyu.edu.hk |
Carcinogensis and radiosensitivity of colorectal cancer The role of autophagy |
|
Email: wing.chi.chan@polyu.edu.hk |
Bioinformatics, role of microRNAs in cancer |
|
Email: lt.lin@polyu.edu.hk |
Cancer signaling cascade responding to radiation therapy; non-coding RNA (lncRNA and miRNA) regulation in cancer therapy; microenvironmental changes in photothermal therapy. |
|
Email: shea.ping.yip@polyu.edu.hk |
|
Monitoring of tumor microenvironment for predicting cancer treatment outcomes |
|
|
Email: alvin.ma@polyu.edu.hk |
The use of autophagy in leukemia diagnosis and prognosis |
|
Email: cl.huang@polyu.edu.hk |
Novel Molecular Assay for Monitoring Minimal Residual Disease in Leukaemia |
|
Email: helen.law@polyu.edu.hk |
Molecular and epigenetic markers related to carcinogenesis and autophagy |
|
Email: jing.cai@polyu.edu.hk |
Radiomics, radiation therapy response assessment and prediction |
|
Email: wing.chi.chan@polyu.edu.hk |
Responsiveness of cancer treatment |
|
Email: lt.lin@polyu.edu.hk |
Molecular imaging - protein-protein interaction, nanoparticle and exosome tracking, bio-distribution and pharmacokinetics; exosome constitution analysis for cancer prognosis. |
|
Email: michael.ying@polyu.edu.hk |
Ultrasound monitoring of treatment responses; Ultrasound assessment of post-radiotherapy complications; Computer-aided assessment |
|
Email: shea.ping.yip@polyu.edu.hk |
|
Dosimetric evaluation of rectal cancer radiotherapy techniques, Natural and artificial radiation protection |
|
|
Email: jing.cai@polyu.edu.hk |
Functional avoidance radiation therapy, smart wearble devices for radiation dosiemtry and protection |
